NEUP vs SPG · rev $15.7M vs rev $3.55B
Neuphoria Therapeutics Inc (NEUP) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
SPG (SPG) common stock.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
NEUP currently screens at market cap $23.6M. SPG currently screens at market cap $0.
Not investment advice. Open the NEUP and SPG stock pages for the full models.
Not investment advice.